ADVANCED PANCREATIC ADENOCARCINOMA
Clinical trials for ADVANCED PANCREATIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PANCREATIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED PANCREATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radiation boost may help control advanced pancreatic cancer
Disease control Recruiting nowThis phase II trial tests whether adding a precise, high-dose form of radiation (SBRT) to standard maintenance chemotherapy can help people with advanced pancreatic cancer live longer. The study enrolls 24 adults whose cancer has not grown after at least four months of initial ch…
Matched conditions: ADVANCED PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Tiny particles, big hope: new combo tackles tough cancers
Disease control Recruiting nowThis study tests whether injecting gadolinium-based nanoparticles (AGuIX) before precise MR-guided radiation can improve tumor control for people with centrally located lung tumors or locally advanced pancreatic cancer. About 100 participants will receive the nanoparticle injecti…
Matched conditions: ADVANCED PANCREATIC ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Arthritis drug shows promise against pancreatic cancer in early trial
Disease control Recruiting nowThis early-phase trial tests whether adding leflunomide, a drug used for rheumatoid arthritis, to standard chemotherapy (gemcitabine) is safe for people with advanced pancreatic cancer that cannot be removed by surgery. About 19 participants will receive the combination to find t…
Matched conditions: ADVANCED PANCREATIC ADENOCARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New hope for pancreatic cancer: targeted drug combo enters Mid-Stage trial
Disease control Recruiting nowThis phase II study tests a new drug called IBI343, which targets a protein on cancer cells, combined with standard chemotherapy (gemcitabine and albumin-bound paclitaxel) in 64 people with advanced pancreatic cancer. The trial has two parts: a safety lead-in and a randomized ext…
Matched conditions: ADVANCED PANCREATIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Scientists hunt for hidden subtypes of cancer wasting
Knowledge-focused Recruiting nowThis study is observing 800 people with advanced lung, colorectal, or pancreatic cancer to understand why some lose weight and muscle (cachexia). Researchers hope to find distinct subtypes of cachexia, which could lead to better, more personalized treatments in the future. Partic…
Matched conditions: ADVANCED PANCREATIC ADENOCARCINOMA
Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC